CD4 and HIV infectious disease: These findings confirm our hypothesis that, given the immune dysregulation that characterizes chronic HIV infection, despite effective ART, PLWH with a low CD4 count remain at risk of lower immune responses to SARS-CoV-2 vaccination, at least in the short term, with potentially negative implications for clinical outcomes.